TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Oslo Cancer Cluster Incubator AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,499
|
1,558
|
1,403 |
| Financial expenses |
1
|
0
|
1 |
| Earnings before taxes |
153
|
89
|
-35 |
| Total assets |
1,005
|
914
|
955 |
| Current assets |
859
|
773
|
817 |
| Current liabilities |
154
|
146
|
219 |
| Equity capital |
851
|
768
|
736 |
| - share capital |
196
|
207
|
221 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
84.7%
|
84.0%
|
77.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.2%
|
5.7%
|
-2.5% |
| Return on assets (ROA) |
15.3%
|
9.7%
|
-3.6% |
| Current ratio |
557.8%
|
529.5%
|
373.1% |
| Return on equity (ROE) |
18.0%
|
11.6%
|
-4.8% |
| Change turnover |
21
|
244
|
12 |
| Change turnover % |
1%
|
19%
|
1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.